Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY Intangible Amortization

Intangible Amortization at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$172.3M+11.6%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$1.57M0.0%
XER
Xeris Biopharma Holdings, Inc.XERS
$2.71M0.0%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$2.72M0.0%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$9.7M+3.8%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$100K-90.0%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s intangible amortization?
Harmony Biosciences Holdings, Inc. (HRMY) reported intangible amortization of $5.96M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s intangible amortization changed year-over-year?
Harmony Biosciences Holdings, Inc.'s intangible amortization decreased by 0.0% year-over-year, from $5.96M to $5.96M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s intangible amortization?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s intangible amortization has grown at a 6.7% compound annual growth rate (CAGR), from $18.42M to $23.85M.
What does intangible amortization mean?
Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.